SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?


To: Terry D. who wrote (2412)8/13/1998 6:07:00 PM
From: shero  Respond to of 3702
 
Why not both?



To: Terry D. who wrote (2412)8/13/1998 6:15:00 PM
From: john dixon  Read Replies (1) | Respond to of 3702
 
Terry, you just verified my point, the family splits. I would guess 80% or more INVESTORS in tcln would take the money. I would. Its an investment, and I might add, a very risky one. My heart goes out to anyone with this terrible disease and I wish them well, but for me its an investment for ROI. People don't buy stock in McDonalds because they like their hamburgers, they buy it hoping everyone else likes their hamburgers.

Thank you for your comments.



To: Terry D. who wrote (2412)8/13/1998 6:19:00 PM
From: EZLibra  Read Replies (1) | Respond to of 3702
 
That's a hypothetical choice for the individual to make. IMO you are both right. What is important is the fact that Techniclone is effecting a cure for some cancers and may do the same for most.

Some like Terry and I are fortunate enough to have the time to spend on the boards doing what we think is educating the public somewhat, not like golfdad but somewhat. The Greatest Story Never Told needs a lot of telling.

I learned today not to stray from the home thread. The curious, cancer victims, investors, even analysts can find their way to SI, Yahoo, ICQ, AOL, Cynthia, Greg, Rubenstein, etc. There are a lot of voices now.

On topic of the stock, Castle Creek filed that they sold 220,000 today. Add that to the 114,000 Marshall Capital (no relation) sold and over half of the final 357 units from the S-3 are gone. The 357 translated to about 590,000 shares. Each share sold gives the company 59-60 cents of course.

The S-3 which has crushed our stock price for nine months is almost done. Get ready for news.